Evidence map›Paper›PMID 41623666›Full record

ArticleInnovation in aging2026

Identifying deprescribing profiles in older adults from 14 countries using the Patient Deprescribing Typology.

Kristie Rebecca Weir, Vincent D Marshall, Katharina Tabea Jungo, Renata Vidonscky Lüthold, Zsofia Rozsnyai, Sven Streit, Sarah E Vordenberg

Abstract read
In one paragraph

Article in Innovation in aging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kristie Rebecca WeirUniversity of Bern, Institute of Primary Health Care (BIHAM), Bern, Switzerland.
Vincent D MarshallUniversity of Michigan College of Pharmacy, Ann Arbor, Michigan, United States.
Katharina Tabea JungoUniversity of Bern, Institute of Primary Health Care (BIHAM), Bern, Switzerland.ORCID https://orcid.org/0000-0002-1782-1345
Renata Vidonscky LütholdUniversity of Bern, Institute of Primary Health Care (BIHAM), Bern, Switzerland.
Zsofia RozsnyaiUniversity of Bern, Institute of Primary Health Care (BIHAM), Bern, Switzerland.
Sven StreitUniversity of Bern, Institute of Primary Health Care (BIHAM), Bern, Switzerland.ORCID https://orcid.org/0000-0002-3813-4616
Sarah E VordenbergUniversity of Michigan College of Pharmacy, Ann Arbor, Michigan, United States.ORCID https://orcid.org/0000-0002-9828-9759

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Objectives: Categorizing older adults by their medication and deprescribing beliefs may support tailored communication and shared decision-making. We aimed to identify latent classes of patients using the Patient Deprescribing Typology. Research Design and Methods: This cross-sectional study used survey responses from 1,131 primary care patients (≥65 years, ≥5 medications) in 14 countries between May 2022 and December 2023. A latent class analysis was conducted using the 4-item Patient Deprescribing Typology, which captures older adults' views on medication importance, learning styles, decision-making preferences, and attitudes toward stopping medications. A multinomial logit model was used to compare the latent classes. Results: Among the 1,131 participants, 55.2% ( Discussion and Implications: While most participants expressed openness to deprescribing, their preferences for information sources, perceived medication importance, and decision-making roles varied. Our findings highlight the need to account for patient differences in deprescribing attitudes. Typologies offer a practical basis for personalized communication and patient-centered interventions.

Indexed as

AttitudesDeprescriptionHealth care communicationMedicationsPatient preferences

Identifiers

PMID41623666
PMCPMC12854721

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.